Get started Log in

084990 — Helixmith Share News

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeSmall CapSucker Stock

Market Cap
KR₩188bn
Enterprise Value
KR₩134bn
Revenue
KR₩3bn

Brief: Helixmith Announces Topline Results From Double-Blind Placebo Controlled Multicenter Study For TADIOS Involving 100 Subjects Infected With COVID-19
03/08/2022 11:41
Brief: Helixmith Announces 50% Enrollment In Its Clinical Trial For COVID-19, Involving Tadios
01/12/2021 11:21
Brief: ViroMed issues 2nd series convertible bonds worth 100 bln won
21/09/2018 09:29
Brief: ViroMed appoints CEO
01/08/2018 08:04
Brief: ViroMed receives patent
25/07/2018 09:33
Brief: ViroMed gets RMAT approval from U.S. FDA for diabetic neuropathy medicine VM202
23/05/2018 11:14
Brief: ViroMed to invest 47.27 bln won on new hardware infrastructure
07/05/2018 07:49
Brief: ViroMed receives Brazil patent
25/04/2018 08:11
Brief: ViroMed receives patent
04/04/2018 07:15
Brief: ViroMed receives patent
14/09/2017 06:16
Brief: ViroMed receives patent
05/07/2017 03:10
Brief: ViroMed raises 139.26 bln won via rights issue
26/10/2016 06:30
Brief: Bluebird bio, ViroMed to develop chimeric antigen receptor T cell therapies
03/12/2015 13:00